MetaCap

Radiopharm Theranostics Limited ADR Company Profile

NASDAQ: RADXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.6304-0.0678 (-9.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Radiopharm Theranostics at a glance

Radiopharm Theranostics Limited ADR (NASDAQ: RADX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Carlton, VIC, Australia. Radiopharm Theranostics is led by Mr. Riccardo Canevari and employs about 14 people. At a market capitalization of $9.9 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001949257, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Radiopharm Theranostics do?

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. It is also developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; and RAD402, a PSA-mAb prostate cancer therapeutic. The company was incorporated in 2021 and is based in Carlton, Australia.

Business description based on the company's public filings.

Company information

Legal name
Radiopharm Theranostics Limited ADR
Ticker
NASDAQ: RADX
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Riccardo Canevari
Employees
14
Headquarters
62 Lygon Street, Carlton, VIC, Australia
Phone
61 3 9824 5254
SEC CIK
0001949257

Companies similar to Radiopharm Theranostics

RADX peer companies
CompanyPrice% ChgMarket capCompare
ASBPAspire-Lakewood Holdings Inc.7.13-5.44%$10.00Mvs RADX
CMMBChemomab Therapeutics Ltd. ADR1.19+4.39%$9.58Mvs RADX
BFRIBiofrontera Inc.0.53-7.02%$9.51Mvs RADX
AEONAEON Biopharma Inc. Class A0.123-7.59%$10.35Mvs RADX
GDTCCytoMed Therapeutics Limited0.755-2.33%$9.01Mvs RADX
CALCCalciMedica Inc.1.26+7.69%$8.69Mvs RADX
OPTHOptimi Health Corp.1.51-13.71%$8.65Mvs RADX
BIVIBioVie Inc. Class A0.80-12.07%$8.58Mvs RADX

Related